Background: Local, sustained delivery of cytokines at a tumor can enhance induction of antitumor immunity and may be a feasible neoadjuvant immunotherapy for breast cancer. We evaluated the ability of intratumoral poly-lactic-acid-encapsulated microspheres (PLAM) containing interleukin 12 (IL-12), tumor necrosis factor α (TNF-α), and granulocyte-macrophage colony stimulating factor (GM-CSF) in a murine model of breast cancer to generate a specific antitumor response.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/41401/1/10434_2004_Article_147.pd
Immunotherapies have significantly improved cancer patient survival, but response rates are still li...
We report the successful encapsulation and elution of recombinant murine IL-12 (rmIL-12) from poly(l...
The identification of tumor-specific antigens and the immune responses directed against them has ins...
Background Sustained intratumoral cytokine release using poly-lactic acid microspheres (PLAMs) can ...
Purpose: Whereas neoadjuvant therapy is emerging as a treatment option in early primary breast cance...
Interleukin-12 (IL-12) is a pro-inflammatory cytokine that plays a major role in immune responses. I...
BACKGROUND: Numerous animal model studies have examined the ability of genetically engineered tumor ...
http://www.liebertonline.comReproduced by generous permission of the publisher.Mice bearing breast t...
Owing to its tumor tropism and prolonged transgene expression, mesenchymal stem cell (MSC) has been ...
Background: We examined alternative methods of delivering cytokines as an adjunct for priming lymph ...
Interleukin-12 immune stimulation lacks efficacy in established solid tumor models. Disruption of tu...
Purpose: Interleukin-12 (IL12) promotes adaptive type I immunity and has demonstrated antitumor effi...
Cancer immunotherapy has emerged as a leading front in cancer treatment. In contrast to other treatm...
Unfavorable ratios between the number and activation status of effector and suppressor immune cells ...
Globally breast cancer has the highest rates of incidence and mortality among women, and the progres...
Immunotherapies have significantly improved cancer patient survival, but response rates are still li...
We report the successful encapsulation and elution of recombinant murine IL-12 (rmIL-12) from poly(l...
The identification of tumor-specific antigens and the immune responses directed against them has ins...
Background Sustained intratumoral cytokine release using poly-lactic acid microspheres (PLAMs) can ...
Purpose: Whereas neoadjuvant therapy is emerging as a treatment option in early primary breast cance...
Interleukin-12 (IL-12) is a pro-inflammatory cytokine that plays a major role in immune responses. I...
BACKGROUND: Numerous animal model studies have examined the ability of genetically engineered tumor ...
http://www.liebertonline.comReproduced by generous permission of the publisher.Mice bearing breast t...
Owing to its tumor tropism and prolonged transgene expression, mesenchymal stem cell (MSC) has been ...
Background: We examined alternative methods of delivering cytokines as an adjunct for priming lymph ...
Interleukin-12 immune stimulation lacks efficacy in established solid tumor models. Disruption of tu...
Purpose: Interleukin-12 (IL12) promotes adaptive type I immunity and has demonstrated antitumor effi...
Cancer immunotherapy has emerged as a leading front in cancer treatment. In contrast to other treatm...
Unfavorable ratios between the number and activation status of effector and suppressor immune cells ...
Globally breast cancer has the highest rates of incidence and mortality among women, and the progres...
Immunotherapies have significantly improved cancer patient survival, but response rates are still li...
We report the successful encapsulation and elution of recombinant murine IL-12 (rmIL-12) from poly(l...
The identification of tumor-specific antigens and the immune responses directed against them has ins...